全文获取类型
收费全文 | 3480篇 |
免费 | 250篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 122篇 |
妇产科学 | 102篇 |
基础医学 | 406篇 |
口腔科学 | 67篇 |
临床医学 | 356篇 |
内科学 | 856篇 |
皮肤病学 | 80篇 |
神经病学 | 192篇 |
特种医学 | 126篇 |
外科学 | 439篇 |
综合类 | 82篇 |
一般理论 | 5篇 |
预防医学 | 238篇 |
眼科学 | 86篇 |
药学 | 302篇 |
中国医学 | 15篇 |
肿瘤学 | 246篇 |
出版年
2024年 | 5篇 |
2023年 | 41篇 |
2022年 | 112篇 |
2021年 | 170篇 |
2020年 | 98篇 |
2019年 | 142篇 |
2018年 | 183篇 |
2017年 | 90篇 |
2016年 | 121篇 |
2015年 | 110篇 |
2014年 | 153篇 |
2013年 | 220篇 |
2012年 | 291篇 |
2011年 | 233篇 |
2010年 | 158篇 |
2009年 | 130篇 |
2008年 | 188篇 |
2007年 | 203篇 |
2006年 | 198篇 |
2005年 | 163篇 |
2004年 | 149篇 |
2003年 | 112篇 |
2002年 | 93篇 |
2001年 | 37篇 |
2000年 | 39篇 |
1999年 | 30篇 |
1998年 | 16篇 |
1997年 | 16篇 |
1996年 | 12篇 |
1995年 | 5篇 |
1994年 | 9篇 |
1993年 | 10篇 |
1992年 | 22篇 |
1991年 | 18篇 |
1990年 | 16篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 17篇 |
1984年 | 9篇 |
1983年 | 7篇 |
1982年 | 4篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1976年 | 4篇 |
1973年 | 8篇 |
1971年 | 5篇 |
排序方式: 共有3740条查询结果,搜索用时 15 毫秒
81.
82.
83.
S Coban E Akbal S Köklü G Köklü MA Ulaşlı S Erkeç B Aktaş O Yüksel E Koçak HR Erdem 《Digestion》2012,86(2):86-93
Background: The exact etiology of irritable bowel syndrome (IBS) remains unclear. Curative treatment is not available and current treatment modalities are mainly directed against the predominant symptoms. There are a few studies reporting the beneficial effects of transcutaneous electrical stimulation in patients with chronic constipation, gastroparesis, and functional dyspepsia. Aim: To investigate whether transcutaneous electrical stimulation is an effective procedure in IBS patients. Methods: IBS patients were randomly placed in vacuum interferential current (IFC) and placebo groups. Both treatments consisted of 12 sessions administered over 4 weeks. Symptoms due to IBS were documented via questionnaires, including the IBS Global Assessment of Improvement Scale, numeric rating scales, visual analogue scale, and IBS Quality of Life Scale at the beginning of, end of, and 1 month after the treatment. Results: Patients in the therapy (29 cases) and placebo (29 cases) groups were homogeneous with respect to demographic data and gastrointestinal system symptoms. When compared to the beginning scores, severity of abdominal discomfort, bloating, and abdominal distension and rumbling improved significantly in either interference or placebo groups at both the end of treatment and 1 month after treatment. In the IFC group, severity of symptoms continued to decrease significantly at 1 month after treatment when compared to scores at just the end of treatment, whereas in the placebo group severity of these symptoms did not change significantly on numeric severity scales. Also, the visual analogue scale of the first month after treatment continued to decrease significantly when compared to the level at the end of treatment in the IFC group. Total quality score increased significantly in the IFC group. Conclusions: Vacuum IFC therapy can significantly improve symptoms and quality of life in patients with IBS. It may represent a novel treatment modality for drug-refractory IBS patients. 相似文献
84.
85.
Orthotopic liver transplantation is the only definitive treatment option for patients dying of liver failure. Since its inception, the technique of liver transplantation and the management of the recipients have evolved considerably. The authors present here an up-to-date overview of the evolution of adult liver transplantation, the evaluation of the recipient and the process of listing and timing of transplantation. The authors conclude with a summary of long-term complications that should be considered when caring for the posttransplant patient. The growing population of patients with liver disease means that more transplants will be performed. Because these patients now live longer lives, it is crucial that clinicians have a basic understanding of the process and outcomes. 相似文献
86.
Juarez JG Harun N Thien M Welschinger R Baraz R Pena AD Pitson SM Rettig M DiPersio JF Bradstock KF Bendall LJ 《Blood》2012,119(3):707-716
CXCL12 and VCAM1 retain hematopoietic stem cells (HSCs) in the BM, but the factors mediating HSC egress from the BM to the blood are not known. The sphingosine-1-phosphate receptor 1 (S1P(1)) is expressed on HSCs, and S1P facilitates the egress of committed hematopoietic progenitors from the BM into the blood. In the present study, we show that both the S1P gradient between the BM and the blood and the expression of S1P(1) are essential for optimal HSC mobilization by CXCR4 antagonists, including AMD3100, and for the trafficking of HSCs during steady-state hematopoiesis. We also demonstrate that the S1P(1) agonist SEW2871 increases AMD3100-induced HSC and progenitor cell mobilization. These results suggest that the combination of a CXCR4 antagonist and a S1P(1) agonist may prove to be sufficient for mobilizing HSCs in normal donors for transplantation purposes, potentially providing a single mobilization procedure and eliminating the need to expose normal donors to G-CSF with its associated side effects. 相似文献
87.
88.
89.
90.